Comparative analysis of autoantibodies targeting peptidylarginine deiminase type 4, mutated citrullinated vimentin and cyclic citrullinated peptides in rheumatoid arthritis: associations with cytokine profiles, clinical and genetic features (original ) (raw )Prevalence of functional haplotypes of the peptidylarginine deiminase citrullinating enzyme gene in patients with rheumatoid arthritis: no influence of the presence of anti-citrullinated peptide antibodies
Bernadett Faragó
Clinical and experimental rheumatology
View PDFchevron_right
Association of Anti–Cyclic citrullinated peptide antibody levels with PADI4 haplotypes in early rheumatoid arthritis and with shared epitope alleles in very late rheumatoid arthritis
Tae-un Han
Arthritis & Rheumatism, 2007
View PDFchevron_right
THE DIAGNOSTIC VALUE OF ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODIES (anti-CCP) IN PATIENTS WITH RHEUMATOID ARTHRITIS DIJAGNOSTI^KO ZNA^ENJE ANTI-CIKLI^NIH CITRULINIRANIH PEPTIDNIH ANTITELA (anti-CCP) KOD PACIJENATA SA REUMATOIDNIM ARTRITISOM
Ljubinka Damjanovska
2007
View PDFchevron_right
Influence of peptidylarginine deiminase type 4 genotype and shared epitope on clinical characteristics and autoantibody profile of rheumatoid arthritis
Rudolf Gruber
Annals of the Rheumatic Diseases, 2008
View PDFchevron_right
AB0284 The Diagnostic Utility of Anti-Mutated Citrullinated Vimentin Antibodies, Anti-Cyclic Citrullinated Peptide Antibodies and Rheumatoid Factor in Rheumatoid Arthritis
Gehan A Hegazy
Annals of the Rheumatic Diseases, 2014
View PDFchevron_right
Diagnostic Value of Autoantibodies Against Citrullinated Peptide Antigens in Rheumatoid Arthritis: Comparison of Different Commercial Kits
Ozlem Şahin
Turkish Journal of Rheumatology, 2011
View PDFchevron_right
The Diagnostic Utility of Anti-Mutated Citrullinated Vimentin Antibodies, Anti-Cyclic Citrullinated Peptide Antibodies and Rheumatoid Factor in Rheumatoid Arthritis
Gehan Hegazy
Egyptian Journal of Rheumatology and Clinical Immunology
View PDFchevron_right
Diagnostic Performance of Anti-Cyclic Citrullinated Peptide Antibodies in Rheumatoid Arthritis and Other Rheumatological Disorders
humberto ventura
International Journal of Current Microbiology and Applied Sciences, 2017
View PDFchevron_right
Comparison of Two Assays to Determine Anti-Citrullinated Peptide Antibodies in Rheumatoid Arthritis in relation to Other Chronic Inflammatory Rheumatic Diseases: Assaying Anti-Modified Citrullinated Vimentin Antibodies Adds Value to Second-Generation Anti-Citrullinated Cyclic Peptides Testing
Mario Salazar-paramo , Arnulfo Hernán Nava-Zavala
BioMed Research International, 2014
View PDFchevron_right
Role of anti-citrullinated protein antibodies in diagnosis and prognosis of rheumatoid arthritis
Jacqueline Dekkers
Archives of Medical Science, 2011
View PDFchevron_right
Polymorphisms and functional haplotype in PADI4: Further evidence for contribution on rheumatoid arthritis susceptibility and anti-cyclic citrullinated peptide antibodies in a western Mexican population
Salvador Muñoz Barrios
View PDFchevron_right
Isotype distribution of ANTI–CYCLIC citrullinated peptide antibodies in undifferentiated arthritis and rheumatoid arthritis reflects an ongoing immune response
Cornelia der Zijde
Arthritis & Rheumatism, 2006
View PDFchevron_right
Multiplex Analyses of Antibodies Against Citrullinated Peptides in Individuals Prior to Development of Rheumatoid Arthritis
Per-johan Jakobsson
Arthritis & Rheumatism, 2013
View PDFchevron_right
Objective: To determine the usefulness of anti-Cyclic Citrullinated Peptide and anti-Mutated Citrullinated Vimentin antibody in the diagnosis of seronegative rheumatoid arthritis
bushra shah
2016
View PDFchevron_right
Shared Epitope and Anti-Cyclic Citrullinated Peptide Antibodies: Relationship with Age at Onset and Duration of Disease in Rheumatoid Arthritis
Benjamín Fernández-gutiérrez
The Journal of Rheumatology, 2009
View PDFchevron_right
Anti -citrullinated peptide antibodies profiling in established rheumatoid arthritis
Onelia Bistoni
Joint Bone Spine, 2017
View PDFchevron_right
Performance of Anti-Cyclic Citrullinated Peptide Assays Differs in Subjects at Increased Risk of Rheumatoid Arthritis and Subjects With Established Disease
Jan Hughes-austin
Arthritis & Rheumatism, 2013
View PDFchevron_right
Differing specificities and isotypes of anti-citrullinated peptide/protein antibodies in palindromic rheumatism and rheumatoid arthritis
juan canete
Arthritis research & therapy, 2017
View PDFchevron_right
Diagnostic performance of anti-citrullinated peptide antibodies for the diagnosis of rheumatoid arthritis: the relevance of likelihood ratios
Donatello Pietrapertosa
Clinical Chemistry and Laboratory Medicine, 2010
View PDFchevron_right
Autoantibodies binding to citrullinated telopeptide of type II collagen and to cyclic citrullinated peptides predict synergistically the development of seropositive rheumatoid arthritis
Jane Ramberg
Annals of the Rheumatic Diseases, 2007
View PDFchevron_right
Spectrum of Anti Citrullinated Peptide Antibodies (ACPA) fine specificities is different between Malaysian and Swedish rheumatoid arthritis patients: Implications for pathogenesis of RA
Lars Alfredsson
Arthritis & rheumatology (Hoboken, N.J.), 2016
View PDFchevron_right
The relationship between the presence of anti-cyclic citrullinated peptide antibodies and clinical phenotype in very early rheumatoid arthritis
M. Cader , Karim Raza
BMC Musculoskeletal Disorders, 2010
View PDFchevron_right
Citrulline Not a Major Determinant in the Recognition of Peptidylarginine Deiminase 2 and 4 by Autoantibodies in Rheumatoid Arthritis
Pooja Naik
Arthritis & Rheumatology, 2020
View PDFchevron_right
Diagnostic and predictive value of anti-cyclic citrullinated protein antibodies in rheumatoid arthritis: a systematic literature review
J. Avouac
Annals of the Rheumatic Diseases, 2005
View PDFchevron_right
Autoantibodies to Peptidylarginine Deiminase 2 Are Associated With Less Severe Disease in Rheumatoid Arthritis
pooja naik
Frontiers in Immunology, 2018
View PDFchevron_right
Anti–Cyclic Citrullinated Peptide Antibodies in the Diagnosis of Rheumatoid Arthritis: Bayes Clears the Haze
matthew liang
Annals of Internal Medicine, 2007
View PDFchevron_right
Association of autoimmunity to peptidyl arginine deiminase type 4 with genotype and disease severity in rheumatoid arthritis
Susan Bartlett
Arthritis & Rheumatism, 2008
View PDFchevron_right
Serum anti-cyclic citrullinated peptide antibodies may predict disease activity in rheumatoid arthritis
Bardia Jamali
Rheumatology International, 2012
View PDFchevron_right
Antibodies to several citrullinated antigens are enriched in the joints of rheumatoid arthritis patients
Karin Lundberg
Arthritis & Rheumatism, 2010
View PDFchevron_right